TP53 and neoplasm: Considering that new cell therapy approaches based on cell reprogramming have a risk of tumor formation, it has recently been proposed that tumor suppressor genes such as p53, p16, and p21 are co-induced with at least one pluripotency factor such as OCT4 or SOX2.